nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—HRH3—epilepsy syndrome	0.146	0.61	CbGaD
Azelastine—CYP2C19—epilepsy syndrome	0.0411	0.172	CbGaD
Azelastine—Mazindol—Midazolam—epilepsy syndrome	0.0353	0.132	CrCrCtD
Azelastine—Mazindol—Diazepam—epilepsy syndrome	0.0315	0.118	CrCrCtD
Azelastine—CYP2D6—epilepsy syndrome	0.0304	0.127	CbGaD
Azelastine—Loxapine—Clobazam—epilepsy syndrome	0.0233	0.087	CrCrCtD
Azelastine—Clozapine—Clonazepam—epilepsy syndrome	0.0219	0.0818	CrCrCtD
Azelastine—ABCB1—epilepsy syndrome	0.0217	0.0909	CbGaD
Azelastine—Loxapine—Diazepam—epilepsy syndrome	0.0216	0.0809	CrCrCtD
Azelastine—Prazepam—Clonazepam—epilepsy syndrome	0.0202	0.0756	CrCrCtD
Azelastine—Clozapine—Clobazam—epilepsy syndrome	0.02	0.0748	CrCrCtD
Azelastine—Chlorcyclizine—Clobazam—epilepsy syndrome	0.02	0.0748	CrCrCtD
Azelastine—Prazepam—Midazolam—epilepsy syndrome	0.0193	0.0721	CrCrCtD
Azelastine—Clozapine—Diazepam—epilepsy syndrome	0.0186	0.0695	CrCrCtD
Azelastine—Prazepam—Clobazam—epilepsy syndrome	0.0185	0.0691	CrCrCtD
Azelastine—Prazepam—Diazepam—epilepsy syndrome	0.0172	0.0643	CrCrCtD
Azelastine—CYP2A6—Amobarbital—epilepsy syndrome	0.00912	0.0271	CbGbCtD
Azelastine—CYP2E1—Felbamate—epilepsy syndrome	0.00794	0.0236	CbGbCtD
Azelastine—CYP2E1—Trimethadione—epilepsy syndrome	0.00794	0.0236	CbGbCtD
Azelastine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00736	0.0219	CbGbCtD
Azelastine—CYP2A6—Propofol—epilepsy syndrome	0.0068	0.0202	CbGbCtD
Azelastine—CYP2E1—Clonazepam—epilepsy syndrome	0.00675	0.0201	CbGbCtD
Azelastine—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00664	0.0198	CbGbCtD
Azelastine—CYP2A6—Phenobarbital—epilepsy syndrome	0.0065	0.0193	CbGbCtD
Azelastine—CYP2B6—Clobazam—epilepsy syndrome	0.00638	0.019	CbGbCtD
Azelastine—CYP2C8—Trimethadione—epilepsy syndrome	0.00593	0.0177	CbGbCtD
Azelastine—CYP1A1—Propofol—epilepsy syndrome	0.00581	0.0173	CbGbCtD
Azelastine—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00558	0.0166	CbGbCtD
Azelastine—CYP1A1—Phenobarbital—epilepsy syndrome	0.00555	0.0165	CbGbCtD
Azelastine—CYP2E1—Rufinamide—epilepsy syndrome	0.0055	0.0164	CbGbCtD
Azelastine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00535	0.0159	CbGbCtD
Azelastine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00529	0.0158	CbGbCtD
Azelastine—CYP2C19—Trimethadione—epilepsy syndrome	0.00498	0.0148	CbGbCtD
Azelastine—CYP2C19—Felbamate—epilepsy syndrome	0.00498	0.0148	CbGbCtD
Azelastine—CYP2B6—Primidone—epilepsy syndrome	0.00494	0.0147	CbGbCtD
Azelastine—CYP2A6—Valproic Acid—epilepsy syndrome	0.00485	0.0145	CbGbCtD
Azelastine—CYP2B6—Phenytoin—epilepsy syndrome	0.00475	0.0141	CbGbCtD
Azelastine—ABCB1—Levetiracetam—epilepsy syndrome	0.00472	0.0141	CbGbCtD
Azelastine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00468	0.0139	CbGbCtD
Azelastine—CYP2E1—Propofol—epilepsy syndrome	0.00449	0.0134	CbGbCtD
Azelastine—CYP2B6—Propofol—epilepsy syndrome	0.00443	0.0132	CbGbCtD
Azelastine—CYP2E1—Phenobarbital—epilepsy syndrome	0.00429	0.0128	CbGbCtD
Azelastine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00423	0.0126	CbGbCtD
Azelastine—CYP2E1—Midazolam—epilepsy syndrome	0.00423	0.0126	CbGbCtD
Azelastine—CYP2B6—Midazolam—epilepsy syndrome	0.00417	0.0124	CbGbCtD
Azelastine—CYP3A5—Carbamazepine—epilepsy syndrome	0.00417	0.0124	CbGbCtD
Azelastine—CYP2C9—Trimethadione—epilepsy syndrome	0.00414	0.0123	CbGbCtD
Azelastine—CYP2E1—Diazepam—epilepsy syndrome	0.00406	0.0121	CbGbCtD
Azelastine—CYP2C19—Clobazam—epilepsy syndrome	0.00406	0.0121	CbGbCtD
Azelastine—CYP2B6—Diazepam—epilepsy syndrome	0.00401	0.0119	CbGbCtD
Azelastine—CYP2C8—Carbamazepine—epilepsy syndrome	0.00401	0.0119	CbGbCtD
Azelastine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00389	0.0116	CbGbCtD
Azelastine—CYP2C8—Primidone—epilepsy syndrome	0.00374	0.0111	CbGbCtD
Azelastine—CYP3A5—Phenytoin—epilepsy syndrome	0.00374	0.0111	CbGbCtD
Azelastine—CYP2C8—Phenytoin—epilepsy syndrome	0.00359	0.0107	CbGbCtD
Azelastine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00336	0.01	CbGbCtD
Azelastine—CYP2C8—Propofol—epilepsy syndrome	0.00335	0.00998	CbGbCtD
Azelastine—CYP3A5—Phenobarbital—epilepsy syndrome	0.00333	0.00992	CbGbCtD
Azelastine—CYP3A5—Midazolam—epilepsy syndrome	0.00329	0.00978	CbGbCtD
Azelastine—ABCB1—Clobazam—epilepsy syndrome	0.00327	0.00975	CbGbCtD
Azelastine—CYP2C8—Phenobarbital—epilepsy syndrome	0.0032	0.00954	CbGbCtD
Azelastine—CYP2B6—Valproic Acid—epilepsy syndrome	0.00316	0.00941	CbGbCtD
Azelastine—CYP3A5—Diazepam—epilepsy syndrome	0.00316	0.0094	CbGbCtD
Azelastine—ABCB1—Lamotrigine—epilepsy syndrome	0.00315	0.00938	CbGbCtD
Azelastine—CYP2C19—Primidone—epilepsy syndrome	0.00314	0.00934	CbGbCtD
Azelastine—CYP1A2—Carbamazepine—epilepsy syndrome	0.0031	0.00923	CbGbCtD
Azelastine—CYP2C8—Diazepam—epilepsy syndrome	0.00304	0.00904	CbGbCtD
Azelastine—CYP2C19—Phenytoin—epilepsy syndrome	0.00302	0.00898	CbGbCtD
Azelastine—CYP1A2—Primidone—epilepsy syndrome	0.0029	0.00862	CbGbCtD
Azelastine—CYP2C19—Propofol—epilepsy syndrome	0.00281	0.00837	CbGbCtD
Azelastine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00279	0.00832	CbGbCtD
Azelastine—ABCB1—Carbamazepine—epilepsy syndrome	0.00271	0.00807	CbGbCtD
Azelastine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00269	0.008	CbGbCtD
Azelastine—CYP2C9—Primidone—epilepsy syndrome	0.00261	0.00777	CbGbCtD
Azelastine—CYP1A2—Propofol—epilepsy syndrome	0.00259	0.00772	CbGbCtD
Azelastine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00259	0.0077	CbGbCtD
Azelastine—CYP2C19—Diazepam—epilepsy syndrome	0.00255	0.00758	CbGbCtD
Azelastine—CYP2C9—Phenytoin—epilepsy syndrome	0.00251	0.00746	CbGbCtD
Azelastine—CYP3A5—Valproic Acid—epilepsy syndrome	0.00249	0.00741	CbGbCtD
Azelastine—CYP2C19—Zonisamide—epilepsy syndrome	0.00249	0.0074	CbGbCtD
Azelastine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00248	0.00738	CbGbCtD
Azelastine—ABCB1—Phenytoin—epilepsy syndrome	0.00243	0.00724	CbGbCtD
Azelastine—CYP3A4—Trimethadione—epilepsy syndrome	0.00241	0.00716	CbGbCtD
Azelastine—CYP3A4—Felbamate—epilepsy syndrome	0.00241	0.00716	CbGbCtD
Azelastine—CYP2C8—Valproic Acid—epilepsy syndrome	0.00239	0.00713	CbGbCtD
Azelastine—CYP1A2—Diazepam—epilepsy syndrome	0.00235	0.007	CbGbCtD
Azelastine—CYP2C9—Propofol—epilepsy syndrome	0.00234	0.00696	CbGbCtD
Azelastine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00226	0.00673	CbGbCtD
Azelastine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00223	0.00665	CbGbCtD
Azelastine—ABCB1—Phenobarbital—epilepsy syndrome	0.00217	0.00646	CbGbCtD
Azelastine—ABCB1—Midazolam—epilepsy syndrome	0.00214	0.00637	CbGbCtD
Azelastine—CYP2D6—Propofol—epilepsy syndrome	0.00214	0.00636	CbGbCtD
Azelastine—CYP2C9—Diazepam—epilepsy syndrome	0.00212	0.00631	CbGbCtD
Azelastine—ABCB1—Diazepam—epilepsy syndrome	0.00206	0.00612	CbGbCtD
Azelastine—CYP3A4—Clonazepam—epilepsy syndrome	0.00205	0.00609	CbGbCtD
Azelastine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00201	0.00598	CbGbCtD
Azelastine—CYP3A4—Clobazam—epilepsy syndrome	0.00196	0.00584	CbGbCtD
Azelastine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00185	0.00552	CbGbCtD
Azelastine—CYP2C19—Topiramate—epilepsy syndrome	0.00181	0.00539	CbGbCtD
Azelastine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00167	0.00497	CbGbCtD
Azelastine—CYP3A4—Rufinamide—epilepsy syndrome	0.00167	0.00496	CbGbCtD
Azelastine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00163	0.00484	CbGbCtD
Azelastine—CYP3A4—Primidone—epilepsy syndrome	0.00152	0.00452	CbGbCtD
Azelastine—CYP3A4—Phenytoin—epilepsy syndrome	0.00146	0.00434	CbGbCtD
Azelastine—CYP3A4—Propofol—epilepsy syndrome	0.00136	0.00405	CbGbCtD
Azelastine—CYP3A4—Phenobarbital—epilepsy syndrome	0.0013	0.00387	CbGbCtD
Azelastine—CYP3A4—Acetazolamide—epilepsy syndrome	0.0013	0.00387	CbGbCtD
Azelastine—CYP3A4—Midazolam—epilepsy syndrome	0.00128	0.00381	CbGbCtD
Azelastine—CYP3A4—Diazepam—epilepsy syndrome	0.00123	0.00367	CbGbCtD
Azelastine—CYP3A4—Zonisamide—epilepsy syndrome	0.0012	0.00358	CbGbCtD
Azelastine—HRH3—hindbrain—epilepsy syndrome	0.00109	0.112	CbGeAlD
Azelastine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000971	0.00289	CbGbCtD
Azelastine—CYP3A4—Topiramate—epilepsy syndrome	0.000876	0.00261	CbGbCtD
Azelastine—HRH3—brainstem—epilepsy syndrome	0.000623	0.0642	CbGeAlD
Azelastine—HRH3—forebrain—epilepsy syndrome	0.000601	0.0619	CbGeAlD
Azelastine—HRH3—telencephalon—epilepsy syndrome	0.000553	0.057	CbGeAlD
Azelastine—HRH3—head—epilepsy syndrome	0.000344	0.0355	CbGeAlD
Azelastine—HRH3—nervous system—epilepsy syndrome	0.000326	0.0336	CbGeAlD
Azelastine—HRH3—central nervous system—epilepsy syndrome	0.000314	0.0324	CbGeAlD
Azelastine—HRH3—cerebellum—epilepsy syndrome	0.000307	0.0316	CbGeAlD
Azelastine—Buclizine—CHRM1—epilepsy syndrome	0.00025	0.129	CrCbGaD
Azelastine—HRH3—brain—epilepsy syndrome	0.000249	0.0257	CbGeAlD
Azelastine—CYP2D6—hindbrain—epilepsy syndrome	0.000191	0.0197	CbGeAlD
Azelastine—ADRA1B—head—epilepsy syndrome	0.000183	0.0189	CbGeAlD
Azelastine—ADRA1B—nervous system—epilepsy syndrome	0.000174	0.0179	CbGeAlD
Azelastine—KCNH2—forebrain—epilepsy syndrome	0.000174	0.0179	CbGeAlD
Azelastine—ADRA1B—central nervous system—epilepsy syndrome	0.000167	0.0172	CbGeAlD
Azelastine—Prazepam—GABRD—epilepsy syndrome	0.000165	0.0853	CrCbGaD
Azelastine—KCNH2—telencephalon—epilepsy syndrome	0.00016	0.0165	CbGeAlD
Azelastine—CYP2A6—cerebellum—epilepsy syndrome	0.000145	0.0149	CbGeAlD
Azelastine—HRH1—forebrain—epilepsy syndrome	0.000139	0.0143	CbGeAlD
Azelastine—ADRA1B—brain—epilepsy syndrome	0.000133	0.0137	CbGeAlD
Azelastine—HRH1—telencephalon—epilepsy syndrome	0.000128	0.0132	CbGeAlD
Azelastine—KCNH2—medulla oblongata—epilepsy syndrome	0.000125	0.0129	CbGeAlD
Azelastine—Prazepam—GABRG2—epilepsy syndrome	0.000125	0.0646	CrCbGaD
Azelastine—CYP2E1—telencephalon—epilepsy syndrome	0.000123	0.0127	CbGeAlD
Azelastine—CYP2A6—brain—epilepsy syndrome	0.000117	0.0121	CbGeAlD
Azelastine—KCNH2—midbrain—epilepsy syndrome	0.000115	0.0118	CbGeAlD
Azelastine—KCNH2—spinal cord—epilepsy syndrome	0.000112	0.0115	CbGeAlD
Azelastine—CYP2D6—brainstem—epilepsy syndrome	0.00011	0.0113	CbGeAlD
Azelastine—CYP2D6—forebrain—epilepsy syndrome	0.000106	0.0109	CbGeAlD
Azelastine—Clozapine—HRH3—epilepsy syndrome	0.000105	0.0545	CrCbGaD
Azelastine—Mazindol—SLC6A4—epilepsy syndrome	0.000103	0.0535	CrCbGaD
Azelastine—Prazepam—GABRA5—epilepsy syndrome	0.0001	0.052	CrCbGaD
Azelastine—Prazepam—GABRB3—epilepsy syndrome	0.0001	0.052	CrCbGaD
Azelastine—KCNH2—head—epilepsy syndrome	9.94e-05	0.0102	CbGeAlD
Azelastine—CYP2D6—telencephalon—epilepsy syndrome	9.74e-05	0.01	CbGeAlD
Azelastine—CYP2E1—medulla oblongata—epilepsy syndrome	9.66e-05	0.00996	CbGeAlD
Azelastine—KCNH2—nervous system—epilepsy syndrome	9.43e-05	0.00972	CbGeAlD
Azelastine—KCNH2—central nervous system—epilepsy syndrome	9.08e-05	0.00935	CbGeAlD
Azelastine—KCNH2—cerebellum—epilepsy syndrome	8.87e-05	0.00914	CbGeAlD
Azelastine—Prazepam—GABRB2—epilepsy syndrome	8.79e-05	0.0455	CrCbGaD
Azelastine—Prazepam—GABRA1—epilepsy syndrome	8.62e-05	0.0447	CrCbGaD
Azelastine—CYP2E1—spinal cord—epilepsy syndrome	8.62e-05	0.00888	CbGeAlD
Azelastine—CYP1A1—head—epilepsy syndrome	8.4e-05	0.00865	CbGeAlD
Azelastine—Clemastine—CYP2D6—epilepsy syndrome	8.37e-05	0.0434	CrCbGaD
Azelastine—CYP2B6—head—epilepsy syndrome	8.16e-05	0.00841	CbGeAlD
Azelastine—HRH1—head—epilepsy syndrome	7.97e-05	0.00821	CbGeAlD
Azelastine—CYP1A1—nervous system—epilepsy syndrome	7.96e-05	0.00821	CbGeAlD
Azelastine—CYP2B6—nervous system—epilepsy syndrome	7.74e-05	0.00797	CbGeAlD
Azelastine—CYP1A1—central nervous system—epilepsy syndrome	7.67e-05	0.0079	CbGeAlD
Azelastine—CYP2E1—head—epilepsy syndrome	7.66e-05	0.00789	CbGeAlD
Azelastine—ABCB1—forebrain—epilepsy syndrome	7.62e-05	0.00785	CbGeAlD
Azelastine—HRH1—nervous system—epilepsy syndrome	7.56e-05	0.00779	CbGeAlD
Azelastine—Loxapine—CHRM3—epilepsy syndrome	7.51e-05	0.0389	CrCbGaD
Azelastine—CYP2B6—central nervous system—epilepsy syndrome	7.45e-05	0.00768	CbGeAlD
Azelastine—HRH1—central nervous system—epilepsy syndrome	7.28e-05	0.0075	CbGeAlD
Azelastine—CYP2E1—nervous system—epilepsy syndrome	7.26e-05	0.00748	CbGeAlD
Azelastine—KCNH2—brain—epilepsy syndrome	7.21e-05	0.00743	CbGeAlD
Azelastine—Loxapine—CHRM1—epilepsy syndrome	7.01e-05	0.0363	CrCbGaD
Azelastine—ABCB1—telencephalon—epilepsy syndrome	7.01e-05	0.00722	CbGeAlD
Azelastine—CYP2E1—central nervous system—epilepsy syndrome	6.99e-05	0.0072	CbGeAlD
Azelastine—CYP2E1—cerebellum—epilepsy syndrome	6.83e-05	0.00704	CbGeAlD
Azelastine—CYP2C8—brain—epilepsy syndrome	6.59e-05	0.00679	CbGeAlD
Azelastine—Clozapine—CHRM3—epilepsy syndrome	6.31e-05	0.0327	CrCbGaD
Azelastine—CYP1A1—brain—epilepsy syndrome	6.09e-05	0.00627	CbGeAlD
Azelastine—CYP2D6—head—epilepsy syndrome	6.06e-05	0.00625	CbGeAlD
Azelastine—CYP2B6—brain—epilepsy syndrome	5.91e-05	0.00609	CbGeAlD
Azelastine—Clozapine—CHRM1—epilepsy syndrome	5.88e-05	0.0305	CrCbGaD
Azelastine—CYP3A4—nervous system—epilepsy syndrome	5.84e-05	0.00602	CbGeAlD
Azelastine—HRH1—brain—epilepsy syndrome	5.78e-05	0.00595	CbGeAlD
Azelastine—CYP2D6—nervous system—epilepsy syndrome	5.75e-05	0.00592	CbGeAlD
Azelastine—Loxapine—CHRM2—epilepsy syndrome	5.72e-05	0.0296	CrCbGaD
Azelastine—Loxapine—HTR7—epilepsy syndrome	5.69e-05	0.0295	CrCbGaD
Azelastine—CYP3A4—central nervous system—epilepsy syndrome	5.63e-05	0.0058	CbGeAlD
Azelastine—CYP2E1—brain—epilepsy syndrome	5.55e-05	0.00572	CbGeAlD
Azelastine—CYP2D6—central nervous system—epilepsy syndrome	5.54e-05	0.0057	CbGeAlD
Azelastine—ABCB1—medulla oblongata—epilepsy syndrome	5.5e-05	0.00567	CbGeAlD
Azelastine—CYP2D6—cerebellum—epilepsy syndrome	5.41e-05	0.00558	CbGeAlD
Azelastine—ABCB1—midbrain—epilepsy syndrome	5.03e-05	0.00518	CbGeAlD
Azelastine—ABCB1—spinal cord—epilepsy syndrome	4.91e-05	0.00506	CbGeAlD
Azelastine—Loxapine—ADRA2A—epilepsy syndrome	4.88e-05	0.0253	CrCbGaD
Azelastine—Clozapine—CHRM2—epilepsy syndrome	4.8e-05	0.0249	CrCbGaD
Azelastine—Clozapine—HTR7—epilepsy syndrome	4.78e-05	0.0248	CrCbGaD
Azelastine—CYP2D6—brain—epilepsy syndrome	4.39e-05	0.00453	CbGeAlD
Azelastine—ABCB1—head—epilepsy syndrome	4.36e-05	0.0045	CbGeAlD
Azelastine—ABCB1—nervous system—epilepsy syndrome	4.14e-05	0.00426	CbGeAlD
Azelastine—Clozapine—ADRA2A—epilepsy syndrome	4.1e-05	0.0212	CrCbGaD
Azelastine—ABCB1—central nervous system—epilepsy syndrome	3.98e-05	0.0041	CbGeAlD
Azelastine—ABCB1—cerebellum—epilepsy syndrome	3.89e-05	0.00401	CbGeAlD
Azelastine—Loxapine—SLC6A4—epilepsy syndrome	3.72e-05	0.0193	CrCbGaD
Azelastine—Headache—Midazolam—epilepsy syndrome	3.67e-05	0.000377	CcSEcCtD
Azelastine—Pruritus—Felbamate—epilepsy syndrome	3.67e-05	0.000377	CcSEcCtD
Azelastine—Body temperature increased—Carbamazepine—epilepsy syndrome	3.67e-05	0.000377	CcSEcCtD
Azelastine—Abdominal pain—Carbamazepine—epilepsy syndrome	3.67e-05	0.000377	CcSEcCtD
Azelastine—Diarrhoea—Diazepam—epilepsy syndrome	3.66e-05	0.000377	CcSEcCtD
Azelastine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	3.66e-05	0.000377	CcSEcCtD
Azelastine—Ill-defined disorder—Pregabalin—epilepsy syndrome	3.66e-05	0.000376	CcSEcCtD
Azelastine—Sinusitis—Topiramate—epilepsy syndrome	3.65e-05	0.000376	CcSEcCtD
Azelastine—Rash—Levetiracetam—epilepsy syndrome	3.65e-05	0.000375	CcSEcCtD
Azelastine—Dermatitis—Levetiracetam—epilepsy syndrome	3.64e-05	0.000375	CcSEcCtD
Azelastine—Asthenia—Zonisamide—epilepsy syndrome	3.64e-05	0.000374	CcSEcCtD
Azelastine—Dry mouth—Valproic Acid—epilepsy syndrome	3.63e-05	0.000374	CcSEcCtD
Azelastine—Agitation—Pregabalin—epilepsy syndrome	3.62e-05	0.000373	CcSEcCtD
Azelastine—Headache—Levetiracetam—epilepsy syndrome	3.62e-05	0.000373	CcSEcCtD
Azelastine—Hypersensitivity—Clonazepam—epilepsy syndrome	3.6e-05	0.000371	CcSEcCtD
Azelastine—Dizziness—Vigabatrin—epilepsy syndrome	3.6e-05	0.00037	CcSEcCtD
Azelastine—Confusional state—Valproic Acid—epilepsy syndrome	3.59e-05	0.000369	CcSEcCtD
Azelastine—Pruritus—Zonisamide—epilepsy syndrome	3.59e-05	0.000369	CcSEcCtD
Azelastine—Hypersensitivity—Phenytoin—epilepsy syndrome	3.58e-05	0.000368	CcSEcCtD
Azelastine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.56e-05	0.000366	CcSEcCtD
Azelastine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.56e-05	0.000366	CcSEcCtD
Azelastine—Malaise—Pregabalin—epilepsy syndrome	3.56e-05	0.000366	CcSEcCtD
Azelastine—Nausea—Propofol—epilepsy syndrome	3.56e-05	0.000366	CcSEcCtD
Azelastine—Tension—Gabapentin—epilepsy syndrome	3.55e-05	0.000365	CcSEcCtD
Azelastine—Vomiting—Fosphenytoin—epilepsy syndrome	3.55e-05	0.000365	CcSEcCtD
Azelastine—Diarrhoea—Felbamate—epilepsy syndrome	3.55e-05	0.000365	CcSEcCtD
Azelastine—Vertigo—Pregabalin—epilepsy syndrome	3.54e-05	0.000364	CcSEcCtD
Azelastine—Abdominal pain—Lamotrigine—epilepsy syndrome	3.54e-05	0.000364	CcSEcCtD
Azelastine—Body temperature increased—Lamotrigine—epilepsy syndrome	3.54e-05	0.000364	CcSEcCtD
Azelastine—Dysgeusia—Gabapentin—epilepsy syndrome	3.54e-05	0.000364	CcSEcCtD
Azelastine—Dizziness—Diazepam—epilepsy syndrome	3.54e-05	0.000364	CcSEcCtD
Azelastine—Infection—Valproic Acid—epilepsy syndrome	3.54e-05	0.000364	CcSEcCtD
Azelastine—Rash—Fosphenytoin—epilepsy syndrome	3.52e-05	0.000362	CcSEcCtD
Azelastine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.52e-05	0.000362	CcSEcCtD
Azelastine—Nervousness—Gabapentin—epilepsy syndrome	3.51e-05	0.000361	CcSEcCtD
Azelastine—Asthenia—Clonazepam—epilepsy syndrome	3.51e-05	0.000361	CcSEcCtD
Azelastine—Rhinitis—Topiramate—epilepsy syndrome	3.5e-05	0.00036	CcSEcCtD
Azelastine—Back pain—Gabapentin—epilepsy syndrome	3.5e-05	0.00036	CcSEcCtD
Azelastine—Headache—Fosphenytoin—epilepsy syndrome	3.5e-05	0.00036	CcSEcCtD
Azelastine—Palpitations—Pregabalin—epilepsy syndrome	3.49e-05	0.000359	CcSEcCtD
Azelastine—Asthenia—Phenytoin—epilepsy syndrome	3.49e-05	0.000358	CcSEcCtD
Azelastine—Nausea—Midazolam—epilepsy syndrome	3.48e-05	0.000358	CcSEcCtD
Azelastine—Hypoaesthesia—Topiramate—epilepsy syndrome	3.48e-05	0.000358	CcSEcCtD
Azelastine—Tachycardia—Valproic Acid—epilepsy syndrome	3.48e-05	0.000357	CcSEcCtD
Azelastine—Diarrhoea—Zonisamide—epilepsy syndrome	3.47e-05	0.000357	CcSEcCtD
Azelastine—Pharyngitis—Topiramate—epilepsy syndrome	3.47e-05	0.000357	CcSEcCtD
Azelastine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.47e-05	0.000357	CcSEcCtD
Azelastine—Pruritus—Clonazepam—epilepsy syndrome	3.46e-05	0.000356	CcSEcCtD
Azelastine—Vomiting—Vigabatrin—epilepsy syndrome	3.46e-05	0.000356	CcSEcCtD
Azelastine—Cough—Pregabalin—epilepsy syndrome	3.44e-05	0.000354	CcSEcCtD
Azelastine—Pruritus—Phenytoin—epilepsy syndrome	3.44e-05	0.000353	CcSEcCtD
Azelastine—Nausea—Levetiracetam—epilepsy syndrome	3.44e-05	0.000353	CcSEcCtD
Azelastine—Rash—Vigabatrin—epilepsy syndrome	3.43e-05	0.000353	CcSEcCtD
Azelastine—Dizziness—Felbamate—epilepsy syndrome	3.43e-05	0.000353	CcSEcCtD
Azelastine—Dermatitis—Vigabatrin—epilepsy syndrome	3.43e-05	0.000352	CcSEcCtD
Azelastine—Pruritus—Oxcarbazepine—epilepsy syndrome	3.42e-05	0.000352	CcSEcCtD
Azelastine—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.42e-05	0.000351	CcSEcCtD
Azelastine—Vision blurred—Gabapentin—epilepsy syndrome	3.41e-05	0.000351	CcSEcCtD
Azelastine—Headache—Vigabatrin—epilepsy syndrome	3.41e-05	0.000351	CcSEcCtD
Azelastine—Hypertension—Pregabalin—epilepsy syndrome	3.41e-05	0.00035	CcSEcCtD
Azelastine—Vomiting—Diazepam—epilepsy syndrome	3.41e-05	0.00035	CcSEcCtD
Azelastine—Rash—Diazepam—epilepsy syndrome	3.38e-05	0.000347	CcSEcCtD
Azelastine—Dermatitis—Diazepam—epilepsy syndrome	3.37e-05	0.000347	CcSEcCtD
Azelastine—Visual impairment—Topiramate—epilepsy syndrome	3.37e-05	0.000346	CcSEcCtD
Azelastine—Myalgia—Pregabalin—epilepsy syndrome	3.36e-05	0.000345	CcSEcCtD
Azelastine—Chest pain—Pregabalin—epilepsy syndrome	3.36e-05	0.000345	CcSEcCtD
Azelastine—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.36e-05	0.000345	CcSEcCtD
Azelastine—Dizziness—Zonisamide—epilepsy syndrome	3.36e-05	0.000345	CcSEcCtD
Azelastine—Headache—Diazepam—epilepsy syndrome	3.36e-05	0.000345	CcSEcCtD
Azelastine—Anxiety—Pregabalin—epilepsy syndrome	3.35e-05	0.000344	CcSEcCtD
Azelastine—Diarrhoea—Clonazepam—epilepsy syndrome	3.35e-05	0.000344	CcSEcCtD
Azelastine—Asthenia—Carbamazepine—epilepsy syndrome	3.33e-05	0.000342	CcSEcCtD
Azelastine—Agitation—Gabapentin—epilepsy syndrome	3.32e-05	0.000342	CcSEcCtD
Azelastine—Diarrhoea—Phenytoin—epilepsy syndrome	3.32e-05	0.000342	CcSEcCtD
Azelastine—Discomfort—Pregabalin—epilepsy syndrome	3.32e-05	0.000341	CcSEcCtD
Azelastine—Nausea—Fosphenytoin—epilepsy syndrome	3.32e-05	0.000341	CcSEcCtD
Azelastine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.31e-05	0.00034	CcSEcCtD
Azelastine—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.3e-05	0.00034	CcSEcCtD
Azelastine—Vomiting—Felbamate—epilepsy syndrome	3.3e-05	0.000339	CcSEcCtD
Azelastine—Dry mouth—Pregabalin—epilepsy syndrome	3.28e-05	0.000338	CcSEcCtD
Azelastine—Pruritus—Carbamazepine—epilepsy syndrome	3.28e-05	0.000337	CcSEcCtD
Azelastine—Rash—Felbamate—epilepsy syndrome	3.27e-05	0.000336	CcSEcCtD
Azelastine—Eye disorder—Topiramate—epilepsy syndrome	3.27e-05	0.000336	CcSEcCtD
Azelastine—Dermatitis—Felbamate—epilepsy syndrome	3.27e-05	0.000336	CcSEcCtD
Azelastine—Malaise—Gabapentin—epilepsy syndrome	3.26e-05	0.000335	CcSEcCtD
Azelastine—Vertigo—Gabapentin—epilepsy syndrome	3.25e-05	0.000334	CcSEcCtD
Azelastine—Headache—Felbamate—epilepsy syndrome	3.25e-05	0.000334	CcSEcCtD
Azelastine—Confusional state—Pregabalin—epilepsy syndrome	3.25e-05	0.000334	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.24e-05	0.000334	CcSEcCtD
Azelastine—Flushing—Topiramate—epilepsy syndrome	3.24e-05	0.000334	CcSEcCtD
Azelastine—Dizziness—Clonazepam—epilepsy syndrome	3.23e-05	0.000333	CcSEcCtD
Azelastine—Nausea—Vigabatrin—epilepsy syndrome	3.23e-05	0.000332	CcSEcCtD
Azelastine—Vomiting—Zonisamide—epilepsy syndrome	3.23e-05	0.000332	CcSEcCtD
Azelastine—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.22e-05	0.000331	CcSEcCtD
Azelastine—Asthenia—Lamotrigine—epilepsy syndrome	3.22e-05	0.000331	CcSEcCtD
Azelastine—Dizziness—Phenytoin—epilepsy syndrome	3.21e-05	0.00033	CcSEcCtD
Azelastine—Rash—Zonisamide—epilepsy syndrome	3.2e-05	0.000329	CcSEcCtD
Azelastine—Infection—Pregabalin—epilepsy syndrome	3.2e-05	0.000329	CcSEcCtD
Azelastine—Paraesthesia—Valproic Acid—epilepsy syndrome	3.2e-05	0.000329	CcSEcCtD
Azelastine—Palpitations—Gabapentin—epilepsy syndrome	3.2e-05	0.000329	CcSEcCtD
Azelastine—Dermatitis—Zonisamide—epilepsy syndrome	3.2e-05	0.000329	CcSEcCtD
Azelastine—Dizziness—Oxcarbazepine—epilepsy syndrome	3.2e-05	0.000329	CcSEcCtD
Azelastine—Nausea—Diazepam—epilepsy syndrome	3.18e-05	0.000327	CcSEcCtD
Azelastine—Headache—Zonisamide—epilepsy syndrome	3.18e-05	0.000327	CcSEcCtD
Azelastine—Dyspnoea—Valproic Acid—epilepsy syndrome	3.17e-05	0.000327	CcSEcCtD
Azelastine—Diarrhoea—Carbamazepine—epilepsy syndrome	3.17e-05	0.000326	CcSEcCtD
Azelastine—Pruritus—Lamotrigine—epilepsy syndrome	3.17e-05	0.000326	CcSEcCtD
Azelastine—Somnolence—Valproic Acid—epilepsy syndrome	3.17e-05	0.000326	CcSEcCtD
Azelastine—ABCB1—brain—epilepsy syndrome	3.16e-05	0.00326	CbGeAlD
Azelastine—Cough—Gabapentin—epilepsy syndrome	3.16e-05	0.000325	CcSEcCtD
Azelastine—Tachycardia—Pregabalin—epilepsy syndrome	3.14e-05	0.000323	CcSEcCtD
Azelastine—Hypertension—Gabapentin—epilepsy syndrome	3.12e-05	0.000321	CcSEcCtD
Azelastine—Vomiting—Clonazepam—epilepsy syndrome	3.11e-05	0.00032	CcSEcCtD
Azelastine—Vomiting—Phenytoin—epilepsy syndrome	3.09e-05	0.000318	CcSEcCtD
Azelastine—Rash—Clonazepam—epilepsy syndrome	3.08e-05	0.000317	CcSEcCtD
Azelastine—Dermatitis—Clonazepam—epilepsy syndrome	3.08e-05	0.000317	CcSEcCtD
Azelastine—Chest pain—Gabapentin—epilepsy syndrome	3.08e-05	0.000317	CcSEcCtD
Azelastine—Myalgia—Gabapentin—epilepsy syndrome	3.08e-05	0.000317	CcSEcCtD
Azelastine—Nausea—Felbamate—epilepsy syndrome	3.08e-05	0.000317	CcSEcCtD
Azelastine—Vomiting—Oxcarbazepine—epilepsy syndrome	3.07e-05	0.000316	CcSEcCtD
Azelastine—Fatigue—Valproic Acid—epilepsy syndrome	3.07e-05	0.000316	CcSEcCtD
Azelastine—Anxiety—Gabapentin—epilepsy syndrome	3.07e-05	0.000316	CcSEcCtD
Azelastine—Dizziness—Carbamazepine—epilepsy syndrome	3.07e-05	0.000315	CcSEcCtD
Azelastine—Diarrhoea—Lamotrigine—epilepsy syndrome	3.07e-05	0.000315	CcSEcCtD
Azelastine—Headache—Clonazepam—epilepsy syndrome	3.06e-05	0.000315	CcSEcCtD
Azelastine—Rash—Phenytoin—epilepsy syndrome	3.06e-05	0.000315	CcSEcCtD
Azelastine—Dermatitis—Phenytoin—epilepsy syndrome	3.06e-05	0.000315	CcSEcCtD
Azelastine—Rash—Oxcarbazepine—epilepsy syndrome	3.05e-05	0.000313	CcSEcCtD
Azelastine—Pain—Valproic Acid—epilepsy syndrome	3.05e-05	0.000313	CcSEcCtD
Azelastine—Constipation—Valproic Acid—epilepsy syndrome	3.05e-05	0.000313	CcSEcCtD
Azelastine—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.04e-05	0.000313	CcSEcCtD
Azelastine—Headache—Phenytoin—epilepsy syndrome	3.04e-05	0.000313	CcSEcCtD
Azelastine—Discomfort—Gabapentin—epilepsy syndrome	3.04e-05	0.000313	CcSEcCtD
Azelastine—Headache—Oxcarbazepine—epilepsy syndrome	3.03e-05	0.000311	CcSEcCtD
Azelastine—Nausea—Zonisamide—epilepsy syndrome	3.01e-05	0.00031	CcSEcCtD
Azelastine—Dry mouth—Gabapentin—epilepsy syndrome	3.01e-05	0.00031	CcSEcCtD
Azelastine—Tension—Topiramate—epilepsy syndrome	2.99e-05	0.000307	CcSEcCtD
Azelastine—Dysgeusia—Topiramate—epilepsy syndrome	2.98e-05	0.000306	CcSEcCtD
Azelastine—Confusional state—Gabapentin—epilepsy syndrome	2.98e-05	0.000306	CcSEcCtD
Azelastine—Clozapine—CYP2C19—epilepsy syndrome	2.96e-05	0.0154	CrCbGaD
Azelastine—Dizziness—Lamotrigine—epilepsy syndrome	2.96e-05	0.000305	CcSEcCtD
Azelastine—Nervousness—Topiramate—epilepsy syndrome	2.96e-05	0.000304	CcSEcCtD
Azelastine—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.95e-05	0.000304	CcSEcCtD
Azelastine—Vomiting—Carbamazepine—epilepsy syndrome	2.95e-05	0.000303	CcSEcCtD
Azelastine—Back pain—Topiramate—epilepsy syndrome	2.94e-05	0.000303	CcSEcCtD
Azelastine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.93e-05	0.000302	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.93e-05	0.000302	CcSEcCtD
Azelastine—Infection—Gabapentin—epilepsy syndrome	2.93e-05	0.000302	CcSEcCtD
Azelastine—Rash—Carbamazepine—epilepsy syndrome	2.92e-05	0.000301	CcSEcCtD
Azelastine—Dermatitis—Carbamazepine—epilepsy syndrome	2.92e-05	0.0003	CcSEcCtD
Azelastine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.91e-05	0.000299	CcSEcCtD
Azelastine—Nausea—Clonazepam—epilepsy syndrome	2.9e-05	0.000299	CcSEcCtD
Azelastine—Headache—Carbamazepine—epilepsy syndrome	2.9e-05	0.000299	CcSEcCtD
Azelastine—Paraesthesia—Pregabalin—epilepsy syndrome	2.89e-05	0.000297	CcSEcCtD
Azelastine—Nausea—Phenytoin—epilepsy syndrome	2.89e-05	0.000297	CcSEcCtD
Azelastine—Tachycardia—Gabapentin—epilepsy syndrome	2.88e-05	0.000296	CcSEcCtD
Azelastine—Dyspnoea—Pregabalin—epilepsy syndrome	2.87e-05	0.000295	CcSEcCtD
Azelastine—Nausea—Oxcarbazepine—epilepsy syndrome	2.87e-05	0.000295	CcSEcCtD
Azelastine—Vision blurred—Topiramate—epilepsy syndrome	2.87e-05	0.000295	CcSEcCtD
Azelastine—Loxapine—HTR2A—epilepsy syndrome	2.86e-05	0.0148	CrCbGaD
Azelastine—Somnolence—Pregabalin—epilepsy syndrome	2.86e-05	0.000294	CcSEcCtD
Azelastine—Vomiting—Lamotrigine—epilepsy syndrome	2.85e-05	0.000293	CcSEcCtD
Azelastine—Rash—Lamotrigine—epilepsy syndrome	2.83e-05	0.000291	CcSEcCtD
Azelastine—Ill-defined disorder—Topiramate—epilepsy syndrome	2.82e-05	0.00029	CcSEcCtD
Azelastine—Dermatitis—Lamotrigine—epilepsy syndrome	2.82e-05	0.00029	CcSEcCtD
Azelastine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.82e-05	0.00029	CcSEcCtD
Azelastine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.82e-05	0.00029	CcSEcCtD
Azelastine—Headache—Lamotrigine—epilepsy syndrome	2.81e-05	0.000289	CcSEcCtD
Azelastine—Agitation—Topiramate—epilepsy syndrome	2.8e-05	0.000288	CcSEcCtD
Azelastine—Fatigue—Pregabalin—epilepsy syndrome	2.78e-05	0.000285	CcSEcCtD
Azelastine—Nausea—Carbamazepine—epilepsy syndrome	2.75e-05	0.000283	CcSEcCtD
Azelastine—Constipation—Pregabalin—epilepsy syndrome	2.75e-05	0.000283	CcSEcCtD
Azelastine—Pain—Pregabalin—epilepsy syndrome	2.75e-05	0.000283	CcSEcCtD
Azelastine—Malaise—Topiramate—epilepsy syndrome	2.74e-05	0.000282	CcSEcCtD
Azelastine—Vertigo—Topiramate—epilepsy syndrome	2.73e-05	0.000281	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.69e-05	0.000277	CcSEcCtD
Azelastine—Palpitations—Topiramate—epilepsy syndrome	2.69e-05	0.000277	CcSEcCtD
Azelastine—Nausea—Lamotrigine—epilepsy syndrome	2.66e-05	0.000274	CcSEcCtD
Azelastine—Cough—Topiramate—epilepsy syndrome	2.66e-05	0.000273	CcSEcCtD
Azelastine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.65e-05	0.000273	CcSEcCtD
Azelastine—Paraesthesia—Gabapentin—epilepsy syndrome	2.65e-05	0.000273	CcSEcCtD
Azelastine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.63e-05	0.000271	CcSEcCtD
Azelastine—Dyspnoea—Gabapentin—epilepsy syndrome	2.63e-05	0.000271	CcSEcCtD
Azelastine—Hypertension—Topiramate—epilepsy syndrome	2.63e-05	0.00027	CcSEcCtD
Azelastine—Somnolence—Gabapentin—epilepsy syndrome	2.62e-05	0.00027	CcSEcCtD
Azelastine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.62e-05	0.00027	CcSEcCtD
Azelastine—Myalgia—Topiramate—epilepsy syndrome	2.59e-05	0.000266	CcSEcCtD
Azelastine—Chest pain—Topiramate—epilepsy syndrome	2.59e-05	0.000266	CcSEcCtD
Azelastine—Anxiety—Topiramate—epilepsy syndrome	2.58e-05	0.000266	CcSEcCtD
Azelastine—Discomfort—Topiramate—epilepsy syndrome	2.56e-05	0.000263	CcSEcCtD
Azelastine—Asthenia—Valproic Acid—epilepsy syndrome	2.55e-05	0.000263	CcSEcCtD
Azelastine—Fatigue—Gabapentin—epilepsy syndrome	2.55e-05	0.000262	CcSEcCtD
Azelastine—Abdominal pain—Pregabalin—epilepsy syndrome	2.54e-05	0.000262	CcSEcCtD
Azelastine—Body temperature increased—Pregabalin—epilepsy syndrome	2.54e-05	0.000262	CcSEcCtD
Azelastine—Dry mouth—Topiramate—epilepsy syndrome	2.53e-05	0.000261	CcSEcCtD
Azelastine—Pain—Gabapentin—epilepsy syndrome	2.52e-05	0.00026	CcSEcCtD
Azelastine—Constipation—Gabapentin—epilepsy syndrome	2.52e-05	0.00026	CcSEcCtD
Azelastine—Pruritus—Valproic Acid—epilepsy syndrome	2.52e-05	0.000259	CcSEcCtD
Azelastine—Confusional state—Topiramate—epilepsy syndrome	2.5e-05	0.000258	CcSEcCtD
Azelastine—Infection—Topiramate—epilepsy syndrome	2.47e-05	0.000254	CcSEcCtD
Azelastine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.44e-05	0.000251	CcSEcCtD
Azelastine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.43e-05	0.00025	CcSEcCtD
Azelastine—Tachycardia—Topiramate—epilepsy syndrome	2.42e-05	0.000249	CcSEcCtD
Azelastine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.41e-05	0.000248	CcSEcCtD
Azelastine—Clozapine—HTR2A—epilepsy syndrome	2.4e-05	0.0124	CrCbGaD
Azelastine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.37e-05	0.000244	CcSEcCtD
Azelastine—Dizziness—Valproic Acid—epilepsy syndrome	2.35e-05	0.000242	CcSEcCtD
Azelastine—Abdominal pain—Gabapentin—epilepsy syndrome	2.33e-05	0.00024	CcSEcCtD
Azelastine—Body temperature increased—Gabapentin—epilepsy syndrome	2.33e-05	0.00024	CcSEcCtD
Azelastine—Asthenia—Pregabalin—epilepsy syndrome	2.31e-05	0.000238	CcSEcCtD
Azelastine—Pruritus—Pregabalin—epilepsy syndrome	2.28e-05	0.000234	CcSEcCtD
Azelastine—Vomiting—Valproic Acid—epilepsy syndrome	2.26e-05	0.000233	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.26e-05	0.000233	CcSEcCtD
Azelastine—Rash—Valproic Acid—epilepsy syndrome	2.25e-05	0.000231	CcSEcCtD
Azelastine—Dermatitis—Valproic Acid—epilepsy syndrome	2.24e-05	0.000231	CcSEcCtD
Azelastine—Headache—Valproic Acid—epilepsy syndrome	2.23e-05	0.000229	CcSEcCtD
Azelastine—Paraesthesia—Topiramate—epilepsy syndrome	2.23e-05	0.000229	CcSEcCtD
Azelastine—Dyspnoea—Topiramate—epilepsy syndrome	2.21e-05	0.000228	CcSEcCtD
Azelastine—Somnolence—Topiramate—epilepsy syndrome	2.21e-05	0.000227	CcSEcCtD
Azelastine—Diarrhoea—Pregabalin—epilepsy syndrome	2.2e-05	0.000227	CcSEcCtD
Azelastine—Clozapine—CYP2D6—epilepsy syndrome	2.2e-05	0.0114	CrCbGaD
Azelastine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.17e-05	0.000224	CcSEcCtD
Azelastine—Fatigue—Topiramate—epilepsy syndrome	2.14e-05	0.00022	CcSEcCtD
Azelastine—Dizziness—Pregabalin—epilepsy syndrome	2.13e-05	0.000219	CcSEcCtD
Azelastine—Constipation—Topiramate—epilepsy syndrome	2.12e-05	0.000218	CcSEcCtD
Azelastine—Pain—Topiramate—epilepsy syndrome	2.12e-05	0.000218	CcSEcCtD
Azelastine—Asthenia—Gabapentin—epilepsy syndrome	2.12e-05	0.000218	CcSEcCtD
Azelastine—Nausea—Valproic Acid—epilepsy syndrome	2.12e-05	0.000218	CcSEcCtD
Azelastine—Pruritus—Gabapentin—epilepsy syndrome	2.09e-05	0.000215	CcSEcCtD
Azelastine—Vomiting—Pregabalin—epilepsy syndrome	2.05e-05	0.000211	CcSEcCtD
Azelastine—Feeling abnormal—Topiramate—epilepsy syndrome	2.05e-05	0.00021	CcSEcCtD
Azelastine—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.03e-05	0.000209	CcSEcCtD
Azelastine—Rash—Pregabalin—epilepsy syndrome	2.03e-05	0.000209	CcSEcCtD
Azelastine—Dermatitis—Pregabalin—epilepsy syndrome	2.03e-05	0.000209	CcSEcCtD
Azelastine—Diarrhoea—Gabapentin—epilepsy syndrome	2.02e-05	0.000208	CcSEcCtD
Azelastine—Headache—Pregabalin—epilepsy syndrome	2.02e-05	0.000207	CcSEcCtD
Azelastine—Body temperature increased—Topiramate—epilepsy syndrome	1.96e-05	0.000202	CcSEcCtD
Azelastine—Abdominal pain—Topiramate—epilepsy syndrome	1.96e-05	0.000202	CcSEcCtD
Azelastine—Dizziness—Gabapentin—epilepsy syndrome	1.95e-05	0.000201	CcSEcCtD
Azelastine—Nausea—Pregabalin—epilepsy syndrome	1.91e-05	0.000197	CcSEcCtD
Azelastine—Vomiting—Gabapentin—epilepsy syndrome	1.88e-05	0.000193	CcSEcCtD
Azelastine—Rash—Gabapentin—epilepsy syndrome	1.86e-05	0.000191	CcSEcCtD
Azelastine—Dermatitis—Gabapentin—epilepsy syndrome	1.86e-05	0.000191	CcSEcCtD
Azelastine—Headache—Gabapentin—epilepsy syndrome	1.85e-05	0.00019	CcSEcCtD
Azelastine—Hypersensitivity—Topiramate—epilepsy syndrome	1.83e-05	0.000188	CcSEcCtD
Azelastine—Asthenia—Topiramate—epilepsy syndrome	1.78e-05	0.000183	CcSEcCtD
Azelastine—Pruritus—Topiramate—epilepsy syndrome	1.76e-05	0.000181	CcSEcCtD
Azelastine—Nausea—Gabapentin—epilepsy syndrome	1.75e-05	0.00018	CcSEcCtD
Azelastine—Diarrhoea—Topiramate—epilepsy syndrome	1.7e-05	0.000175	CcSEcCtD
Azelastine—Dizziness—Topiramate—epilepsy syndrome	1.64e-05	0.000169	CcSEcCtD
Azelastine—Vomiting—Topiramate—epilepsy syndrome	1.58e-05	0.000162	CcSEcCtD
Azelastine—Clozapine—ABCB1—epilepsy syndrome	1.57e-05	0.00813	CrCbGaD
Azelastine—Rash—Topiramate—epilepsy syndrome	1.57e-05	0.000161	CcSEcCtD
Azelastine—Dermatitis—Topiramate—epilepsy syndrome	1.56e-05	0.000161	CcSEcCtD
Azelastine—Headache—Topiramate—epilepsy syndrome	1.56e-05	0.00016	CcSEcCtD
Azelastine—Nausea—Topiramate—epilepsy syndrome	1.48e-05	0.000152	CcSEcCtD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.89e-06	3.88e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.88e-06	3.86e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.88e-06	3.86e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.87e-06	3.84e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	1.86e-06	3.82e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AVP—epilepsy syndrome	1.86e-06	3.81e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.86e-06	3.81e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	1.85e-06	3.8e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.85e-06	3.79e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.84e-06	3.77e-05	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.82e-06	3.73e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.81e-06	3.72e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.81e-06	3.71e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.8e-06	3.69e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.8e-06	3.68e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.79e-06	3.68e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.79e-06	3.67e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.78e-06	3.66e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.77e-06	3.63e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.77e-06	3.63e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.77e-06	3.63e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.76e-06	3.62e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—TH—epilepsy syndrome	1.76e-06	3.61e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	1.76e-06	3.61e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.76e-06	3.61e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	1.76e-06	3.61e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	1.74e-06	3.57e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	1.74e-06	3.57e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.74e-06	3.56e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.73e-06	3.56e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.72e-06	3.53e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.71e-06	3.51e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	1.71e-06	3.51e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.7e-06	3.49e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.7e-06	3.49e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.7e-06	3.49e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.7e-06	3.48e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.7e-06	3.48e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—AGT—epilepsy syndrome	1.68e-06	3.45e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	1.68e-06	3.45e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.68e-06	3.44e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.68e-06	3.44e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.68e-06	3.43e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.67e-06	3.43e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.67e-06	3.42e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—APOE—epilepsy syndrome	1.65e-06	3.38e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.65e-06	3.38e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.64e-06	3.37e-05	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.64e-06	3.37e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.64e-06	3.36e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.63e-06	3.35e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.63e-06	3.35e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.63e-06	3.34e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	1.63e-06	3.33e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.61e-06	3.31e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.61e-06	3.3e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	1.6e-06	3.29e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.6e-06	3.27e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	1.59e-06	3.26e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CAT—epilepsy syndrome	1.58e-06	3.24e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	1.58e-06	3.24e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.58e-06	3.24e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.57e-06	3.23e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—TH—epilepsy syndrome	1.57e-06	3.22e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.56e-06	3.19e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.55e-06	3.18e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	1.55e-06	3.17e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.55e-06	3.17e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	1.55e-06	3.17e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.55e-06	3.17e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.54e-06	3.16e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.54e-06	3.16e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.54e-06	3.16e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	1.54e-06	3.16e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.54e-06	3.15e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—TH—epilepsy syndrome	1.54e-06	3.15e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.53e-06	3.14e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.53e-06	3.14e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.53e-06	3.13e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.52e-06	3.12e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.52e-06	3.11e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.52e-06	3.11e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.51e-06	3.1e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.49e-06	3.05e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.49e-06	3.05e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.49e-06	3.05e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.47e-06	3.02e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.47e-06	3.02e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	1.47e-06	3.02e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	1.47e-06	3.01e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.47e-06	3.01e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.46e-06	2.98e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.45e-06	2.98e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.45e-06	2.97e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.45e-06	2.97e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.44e-06	2.95e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	1.44e-06	2.95e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—TH—epilepsy syndrome	1.43e-06	2.94e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.43e-06	2.94e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.43e-06	2.93e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.42e-06	2.91e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.41e-06	2.89e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.41e-06	2.89e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	1.41e-06	2.89e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.4e-06	2.87e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.38e-06	2.83e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.38e-06	2.82e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.36e-06	2.79e-05	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—AKT1—epilepsy syndrome	1.36e-06	2.78e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.36e-06	2.78e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.35e-06	2.77e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.33e-06	2.73e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.33e-06	2.73e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.33e-06	2.73e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.33e-06	2.73e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.33e-06	2.72e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.31e-06	2.69e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.31e-06	2.69e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.31e-06	2.68e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.3e-06	2.67e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.3e-06	2.67e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.3e-06	2.67e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.3e-06	2.67e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.3e-06	2.66e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ALB—epilepsy syndrome	1.29e-06	2.65e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.28e-06	2.63e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.28e-06	2.62e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CAT—epilepsy syndrome	1.26e-06	2.59e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.26e-06	2.58e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.26e-06	2.57e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.24e-06	2.55e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.24e-06	2.53e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.23e-06	2.52e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—APOE—epilepsy syndrome	1.23e-06	2.52e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	1.23e-06	2.52e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—TH—epilepsy syndrome	1.23e-06	2.51e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	1.22e-06	2.51e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.21e-06	2.49e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.21e-06	2.48e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.21e-06	2.48e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.21e-06	2.47e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.2e-06	2.45e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.19e-06	2.44e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.18e-06	2.43e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.18e-06	2.42e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.18e-06	2.41e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.17e-06	2.4e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.16e-06	2.38e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.15e-06	2.36e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.15e-06	2.36e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.14e-06	2.35e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.14e-06	2.34e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	1.13e-06	2.32e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.13e-06	2.31e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—POMC—epilepsy syndrome	1.12e-06	2.3e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	1.12e-06	2.29e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.12e-06	2.29e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	1.1e-06	2.24e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	1.09e-06	2.24e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.08e-06	2.21e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.07e-06	2.19e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.06e-06	2.18e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—POMC—epilepsy syndrome	1.06e-06	2.17e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.04e-06	2.14e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.03e-06	2.11e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.02e-06	2.1e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.02e-06	2.09e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.02e-06	2.09e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	1.01e-06	2.08e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.01e-06	2.07e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.01e-06	2.07e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.01e-06	2.06e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.01e-06	2.06e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AGT—epilepsy syndrome	1e-06	2.06e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	9.95e-07	2.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	9.9e-07	2.03e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOE—epilepsy syndrome	9.82e-07	2.01e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	9.82e-07	2.01e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—POMC—epilepsy syndrome	9.69e-07	1.99e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ALB—epilepsy syndrome	9.63e-07	1.97e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.6e-07	1.97e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.49e-07	1.95e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TH—epilepsy syndrome	9.46e-07	1.94e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AGT—epilepsy syndrome	9.45e-07	1.94e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AGT—epilepsy syndrome	9.37e-07	1.92e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOE—epilepsy syndrome	9.26e-07	1.9e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	9.24e-07	1.89e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	9.19e-07	1.88e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOE—epilepsy syndrome	9.18e-07	1.88e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	9.15e-07	1.88e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	9.13e-07	1.87e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	9.13e-07	1.87e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	9.01e-07	1.85e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	8.94e-07	1.83e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	8.92e-07	1.83e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	8.89e-07	1.82e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ALB—epilepsy syndrome	8.83e-07	1.81e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	8.65e-07	1.77e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—POMC—epilepsy syndrome	8.65e-07	1.77e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—POMC—epilepsy syndrome	8.44e-07	1.73e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	8.43e-07	1.73e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	8.39e-07	1.72e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.36e-07	1.71e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	8.29e-07	1.7e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	8.05e-07	1.65e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AGT—epilepsy syndrome	8e-07	1.64e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	7.98e-07	1.64e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—POMC—epilepsy syndrome	7.95e-07	1.63e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	7.89e-07	1.62e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—POMC—epilepsy syndrome	7.88e-07	1.62e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ALB—epilepsy syndrome	7.88e-07	1.62e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOE—epilepsy syndrome	7.84e-07	1.61e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	7.83e-07	1.61e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CAT—epilepsy syndrome	7.79e-07	1.6e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	7.77e-07	1.59e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	7.73e-07	1.58e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ALB—epilepsy syndrome	7.69e-07	1.58e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	7.59e-07	1.56e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.58e-07	1.55e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ALB—epilepsy syndrome	7.25e-07	1.49e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	7.22e-07	1.48e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ALB—epilepsy syndrome	7.19e-07	1.47e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.04e-07	1.44e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	7.03e-07	1.44e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	6.9e-07	1.41e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—POMC—epilepsy syndrome	6.74e-07	1.38e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	6.73e-07	1.38e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	6.34e-07	1.3e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	6.29e-07	1.29e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.18e-07	1.27e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ALB—epilepsy syndrome	6.14e-07	1.26e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.05e-07	1.24e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—AKT1—epilepsy syndrome	5.68e-07	1.17e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	5.37e-07	1.1e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.2e-07	1.07e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	4.96e-07	1.02e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.74e-07	9.72e-06	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	4.59e-07	9.4e-06	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	4.49e-07	9.21e-06	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	4.49e-07	9.2e-06	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AKT1—epilepsy syndrome	4.48e-07	9.19e-06	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKT1—epilepsy syndrome	4.24e-07	8.68e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.15e-07	8.5e-06	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKT1—epilepsy syndrome	3.88e-07	7.96e-06	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.47e-07	7.11e-06	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKT1—epilepsy syndrome	3.38e-07	6.94e-06	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.19e-07	6.54e-06	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	3.16e-07	6.48e-06	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.7e-07	5.54e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.08e-07	4.27e-06	CbGpPWpGaD
